CFN Media Examines Medical Marijuana, Inc.'s Investment in AXIM Biotechnolgies' Groundbreaking CBD and CBG Research
(firmenpresse) - REDONDO BEACH, CA -- (Marketwired) -- 07/14/16 -- CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article and interview discussing Medical Marijuana Inc.'s (OTC PINK: MJNA) major investment in AXIM Biotechnologies.
AXIM is developing the world's first controlled-release functional chewing gum to effectively treat chronic pain and spasticity in patients with multiple sclerosis. In conjunction with the Free University of Amsterdam and other institutions, the company is conducting research under strict FDA/EMA guidelines with a 24-month timeline prior to registration.
The company's researchers believe that the act of chewing -- known as mastication in the medical community -- could have neuroprotective benefits. According to a growing body of research, the act of chewing could prevent cognitive dysfunction by changing internal carotid arterial blood flow and thereby increasing cerebral blood flow. Chewing gum could therefore cause regional increases in neuronal activity that could be cognitively beneficial.
To read the full article on CannabisFN.com, click the following link or copy and paste the URL into your browser:
Learn how to become a CFN Media featured company, brand or entrepreneur:
Download the CFN Media iOS mobile app to access the world of cannabis from your smart phone:
Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone:
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit .
The Company is committed to consistently providing the highest-quality CBD hemp oil products on the market. To see Medical Marijuana, Inc.'s video statement, . Shareholders are also encouraged to visit the for discounted products.
CFN Media
Frank Lane
206-369-7050
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 14.07.2016 - 13:23 Uhr
Sprache: Deutsch
News-ID 483381
Anzahl Zeichen: 0
contact information:
Town:
REDONDO BEACH, CA
Kategorie:
Alternative
Diese Pressemitteilung wurde bisher 301 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"CFN Media Examines Medical Marijuana, Inc.'s Investment in AXIM Biotechnolgies' Groundbreaking CBD and CBG Research"
steht unter der journalistisch-redaktionellen Verantwortung von
CFN Media Group (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
